Abstract
Clinical pharmacists in most primary care settings across Europe do not offer a reimbursed medication review service. This paper describes the development, implementation, and evaluation of a program in Slovenia that allows all general practitioners to refer patients to clinical pharmacists in primary care settings for a medication review. Between 2012 and 2015, the Health Insurance Institute of Slovenia proposed, funded and evaluated a pilot trial and recommended that the service be extended to all public health insurance beneficiaries in Slovenia. Following successful negotiations, the program (Pharmacist Consultant) has been available in all Slovenian primary care settings since 2018. It was evaluated internally with various questionnaires and externally with three studies that reported fewer medication-related problems, fewer drug-drug interactions, cost effectiveness, better treatment guidelines adherence and better humanistic clinical outcomes. The results demonstrate that including clinical pharmacists in primary care settings is particularly beneficial for patients with multiple diseases and medications, who are often elderly people. Future research should examine the service with improved methodologies (e.g., prospective studies with a larger sample size, measures of clinical outcomes and long-term follow-up). In the context of Slovenia, studies should also examine the effects of further integration of clinical pharmacists in patient care (e.g., through patient monitoring, dependent or independent prescribing and medication reviews in hospitals).
Similar content being viewed by others
References
Stuhec M, Gorenc K. Positive impact of clinical pharmacist interventions on antipsychotic use in patients on excessive polypharmacy evidenced in a retrospective cohort study. Global Psych. 2019;2:155–64.
Stuhec M, Gorenc K, Zelko E. Evaluation of a collaborative care approach between general practitioners and clinical pharmacists in primary care community settings in elderly patients on polypharmacy in Slovenia: a cohort retrospective study reveals positive evidence for implementation. BMC Health Serv Res. 2019;19:118.
Rieckert A, Trampisch US, Klaaßen-Mielke R, Drewelow E, Esmail A, Johansson T, et al. Polypharmacy in older patients with chronic diseases: a cross-sectional analysis of factors associated with excessive polypharmacy. BMC Fam Pract. 2018;19:113.
Hajjar ER, Cafiero AC, Hanlon JT. Polypharmacy in elderly patients. Am J Geriatr Pharmacother. 2007;5:345–51.
Maher RL, Hanlon J, Hajjar ER. Clinical consequences of polypharmacy in elderly. Expert Opin Drug Saf. 2014;13:57–65.
Davies LE, Spiers G, Kingston A, Todd A, Adamson J, Hanratty B. Adverse outcomes of polypharmacy in older people: systematic review of reviews. J Am Med Dir Assoc. 2020;21:181–7.
Slovenian Ambulatory Medication Consumption: National Institute of Public Health of the Republic of Slovenia. https://www.nijz.si/sites/www.nijz.si/files/datoteke/poraba_ambulantno_predpisanih_zdravil_v_sloveniji_2014.pdf (2014). Accessed 15 June 2021.
Chisholm-Burns MA, Kim Lee J, Spivey CA, Slack M, Herrier RN, Hall-Lipsy E, et al. US pharmacists’ effect as team members on patient care: systematic review and meta-analyses. Med Care. 2010;48:923–33.
Scheepers-Hoeks A, Seidling H. How to grow clinical pharmacy and keep adding value. 16th Congress of the European Association of Hospital Pharmacists. Seminar 5, EAHP 2011.
Mason JD, Colley CA. Effectiveness of an ambulatory care clinical pharmacist: a controlles trial. Ann Pharmacother. 1993;27:555–9.
Komwong D, Greenfield G, Zaman H, Majeed A, Hayhoe B. Clinical pharmacists in primary care: a safe solution to the workforce crisis? J R Soc Med. 2018;111:120–4.
Medical Research Council: Developing and evaluating complex interventions. https://mrc.ukri.org/documents/pdf/complex-interventions-guidance/ (2008). Accessed Sep 2020.
Damschroder LJ, Aron DC, Keith RE, Kirsh SR, Alexander JA, Lowery JC. Fostering implementation of health services research findings into practice: a consolidated framework for advancing implementation science. Implement Sci. 2009;7(4):50.
Florentinus SR, van Hulten R, Kloth ME, Heerdink ER, Griens AM, Leufkens HG, et al. Netherlands Institute for Health Services Research. The effect of pharmacotherapy audit meetings on early new drug prescribing by general practitioners. Ann Pharmacother. 2007;41:319–24.
Marušič PA. Pharmacotherapy reviews in hospitals and at an outpatient clinic—experience and evaluation of work. Pharmacotherapy reviews in hospitals and at an outpatient clinic Farmakoterapijski pregledi v bolnišnicah in v ambulantah—izkušnje in evalvacija dela. Farmacevtski vestnik. 2014;65:187–90.
Mrak J, Kenk N, Premuš Marušič A, Prislan M, Fuerst J. From developmental task to systemic introduction on pharmaceutical consultancy program. Med Razgl. 2017;56:75–81.
Slovenian Pharmacy Act (Pharmacy Practice Act): Official Journal Republic of Slovenia, number 85/16 http://www.pisrs.si/Pis.web/pregledPredpisa?id=ZAKO7375 (2016). Accessed 9 Feb 2021.
Health Insurance Institute of Slovenia: http://api.zzzs.si/egradivap/827714AA6BBB87D2C1257FD40041FCC2. Accessed 25 Feb 2021.
Leaftet (Pharmacist Consultant): Health Insurance Institute of Slovenia. https://api.zzzs.si/ZZZS/info/egradiva.nsf/o/F11F2A26A4332A61C125829B0038245F?OpenDocument. Accessed 25 Feb 2021.
Stuhec M, Flegar I, Zelko E, Kovačič A, Zabavnik V.: Clinical pharmacist interventions in cardiovascular disease pharmacotherapy in elderly patients on excessive polypharmacy: a retrospective pre-post observational multicentric study. Wien Klin Wochenschr. (2021). doi: https://doi.org/10.1007/s00508-020-01801-y. Epub ahead of print. PMID: 33471149.
Stuhec M, Bratović N, Mrhar A. Impact of clinical pharmacist’s interventions on pharmacotherapy management in elderly patients on polypharmacy with mental health problems including quality of life: a prospective non-randomized study. Sci Rep. 2019;14:16856.
Gorenc K.: Klinično ovrednotenje intervencij farmacevta v zdravstvenem domu Ljutomer pri starejših bolnikih s polifarmakoterapijo = Clinical evaluation of pharmacist consultant interventions in community health centre Ljutomer in elderly patients treated with polypharmacy: magistrska naloga. Master’s thesis. http://www.ffa.uni-lj.si/docs/default-source/knjiznicadoc/magistrske/2017/gorenc_katja_mag_nal_2017.pdf?sfvrsn=2. Accessed 25 Feb 2021.
Stubbings J, Nutescu E, Durley SF, Bauman JL. Payment for clinical pharmacy services revisited. Pharmacotherapy. 2011;31:1–8.
Stuhec M, Lah L.: Clinical pharmacist interventions in elderly patients with mental disorders in primary care focused on psychotropics: a retrospective pre-post observational study. Ther Adv Psychopharmacol. 2021;11:20451253211011007. doi: https://doi.org/10.1177/20451253211011007.
Department of Health: A Guide to Implementing Nurse and Pharmacist Independent Prescribing within the NHS in England. http://webarchive.nationalarchives.gov.uk/20130107105354/http://www.dh.gov.uk/prod_consum_dh/groups/dh_digitalassets/@dh/@en/documents/digitalasset/dh_4133747.pdf. Accessed 19 Feb 2021.
Funding
None.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflicts of interest
The author declares that they have no conflict of interest.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Stuhec, M. Clinical pharmacist consultant in primary care settings in Slovenia focused on elderly patients on polypharmacy: successful national program from development to reimbursement. Int J Clin Pharm 43, 1722–1727 (2021). https://doi.org/10.1007/s11096-021-01306-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11096-021-01306-2